2021 Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis Group Chronic Malignancies Working Party (CMWP) 1st listed author D McLornan Journal Bone Marrow Transplant.
2021 IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study Group Chronic Malignancies Working Party (CMWP) 1st listed author Sarah Lawless Journal Clin Lymphoma Myeloma Leuk.
2021 Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party Group Chronic Malignancies Working Party (CMWP) 1st listed author Patrick J Hayden Journal Bone Marrow Transplant.
2021 Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia Group Chronic Malignancies Working Party (CMWP) 1st listed author Johannes Schetelig Journal Front Immunol.
2021 Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Mitja Nabergoj Journal Bone Marrow Transplant.
2021 Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Laurent Garderet Journal Eur J Haematol.
2021 Thiotepa-busulfan-fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Giorgia Battipaglia Journal Bone Marrow Transplant.
2021 [CAR-T CELLS: How does the EBMT registry monitor European activities, identify hurdles and prepare for changes in regulations] Group Acute Leukemia Working Party (ALWP) Severe Aplastic Anaemia Working Party (SAAWP) Chronic Malignancies Working Party (CMWP) Cellular Therapy & Immunobiology Working Party (CTIWP) Inborn Errors Working Party (IEWP) 1st listed author Christian Chabannon Journal Bull Cancer.
2021 Association of pre-existing comorbidities with outcome of allogeneic hematopoietic cell transplantation. A retrospective analysis from the EBMT Group Acute Leukemia Working Party (ALWP) Severe Aplastic Anaemia Working Party (SAAWP) Autoimmune Diseases Working Party (ADWP) Chronic Malignancies Working Party (CMWP) Inborn Errors Working Party (IEWP) Infectious Diseases Working Party (IDWP) Transplant Complications Working Party (TCWP) Lymphoma Working Party (LWP) Paediatric Diseases Working Party (PDWP) 1st listed author Olaf Penack Journal Bone Marrow Transplant.
2021 Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey Group Chronic Malignancies Working Party (CMWP) Infectious Diseases Working Party (IDWP) 1st listed author Leopold Sellner Journal Bone Marrow Transplant.
2021 Allogeneic haematopoietic cell transplantation for myelofibrosis: proposed definitions and management strategies for graft failure, poor graft function and relapse: best practice recommendations of the EBMT Chronic Malignancies Working Party Group Chronic Malignancies Working Party (CMWP) 1st listed author Donal P McLornan Journal Leukemia.
2021 Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Nicolaus Kröger Journal Leukemia.